Evaluates biological activity of food-grade rHSA produced in Kluyveromyces lactis, suggesting safe sourcing for drug production.
can serve as an effective bioreactor for producing food-grade and cost-effective rHSA that is safe, and can help meet the growing global demand for HSA from non-animal sources for drug production and cell culture.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: